loading...| Preferred Name |
Canagliflozin Anhydrous |
|
| Synonyms |
|
|
| Definitions |
The anhydrous form of canagliflozin, a C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C91019 |
|
| CAS_Registry |
842133-18-0 |
|
| Chemical_Formula |
C24H25FO5S |
|
| code |
C91019 |
|
| Contributing_Source |
FDA |
|
| definition |
The anhydrous form of canagliflozin, a C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia. |
|
| FDA_UNII_Code |
6S49DGR869 |
|
| in_subset | ||
| label |
Canagliflozin Anhydrous |
|
| Preferred_Name |
Canagliflozin Anhydrous |
|
| prefixIRI |
NCIT:C91019 |
|
| prefLabel |
Canagliflozin Anhydrous |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C2983989 |
|
| subClassOf |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://purl.bioontology.org/ontology/SNOMEDCT/1268978008 | SNOMEDCT | LOOM | |
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C91019 | NCIT | LOOM | |
| http://purl.bioontology.org/ontology/RXNORM/1546031 | RXNORM | LOOM | |
| http://id.nlm.nih.gov/mesh/D000068896 | MDM | LOOM |